Skip to main content

Cancer Center members contribute to the mission of the Center via their participation in research, including laboratory, clinical, and population- based efforts. Membership alignment is limited to one program.

Primary Criteria for Membership

  • Active cancer-related research interests as a professional focus
  • Interest in the application of research to improve cancer care

Learn more about membership types and categories.

HCI Membership Benefits At-a-Glance

Leadership Type 1 Type 2 Type 3
Cancer Center Leadership X    
HCI Translational Scholar X    
Strategic planning X X X
Input on Program, Shared Resource Development X X  
Institutional Funding Opportunities      
Program Funding X* X*  
Center for Investigational Therapeutics Funding X* X*  
Team Science Acceleration Funding X* X*  
Translational Science Initiative Funding X* X*  
CCSG Supplement Funding X X  
ACS Seed Funding   X  
HCI-managed limited submission extramural funding opportunities X X X
Information and Community      
Funding announcements X X X
HCI Newsletter X X X
Attend retreats, symposia, seminars, etc. X X X
Nominate and host HCI Seminar Series speakers X X X
HCI Investigator designation X X X
Scientific and Administrative Support      
Shared Resources access, including Cancer Biostatistics support X X X
Clinical Research Support (cancer-relevant interventional treatment trials) X X X

* Some restrictions apply; see Benefits and Responsibilities.

Comprehensive Cancer Center Director

Comprehensive Cancer Center Deputy Director

Senior Directors

Neeraj Agarwal, MD
Clinical Research
Donald Ayer, PhD
Co-Director, Cancer Research Training and Education Coordination
Rachel Ceballos, PhD
Community Outreach and Engagement
Max Loveless, MBA
Senior Administrative Director
Martin McMahon, PhD
Preclinical Translation
Tracy Onega, PhD, MS
Population Sciences
Aik Choon Tan, PhD
Data Science and AI
Katharine Ullman, PhD
Director, Cancer Research Training and Education Coordination
Alana Welm, PhD
Basic Science
David Wetter, PhD, MS
CHES

Program Leadership

Nuclear Control of Cell Growth and Differentiation

Jay Gertz, PhD
Co-Leader
Jared Rutter, PhD
Co-Leader

Cell Response and Regulation

Shannon Buckley
Co-Leader
Sheri Holmen, PhD
Co-Leader

Experimental Therapeutics

Howard Colman, MD, PhD
Co-Leader
Martin McMahon, PhD
Co-Leader

Cancer Control and Population Sciences

Jennifer Doherty, MS, PhD
Co-Leader
Kimberly Kaphingst, ScD
Co-Leader
Kathleen Mooney, PhD
Co-Leader